Status:
UNKNOWN
Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics
Lead Sponsor:
Cairo University
Conditions:
Anesthesia Emergence Delirium
Eligibility:
All Genders
2-5 years
Phase:
PHASE1
PHASE2
Brief Summary
Emergence agitation (EA) is a post-operative behavioral disturbance was first reported in early 1960s. EA is a term used to describe non purposeful restlessness and agitation, thrashing, crying or moa...
Detailed Description
Sevoflurane induced anesthesia does not cause significant cardiac depression and dysrrhythmias as compared to halothane. Sevoflurane anesthesia is also easy to titrate for maintaining an adequate leve...
Eligibility Criteria
Inclusion
- ASA physical status II
- ages from 2-5 years.
- weight more than 6 kg.
- scheduled for cardiac catheterization procedure not exceeding 3 hours.
Exclusion
- psychological disorder or cognitive delay.
- chronic or acute intake of any sedative drug or anticonvulsant drugs.
- Any neurological condition that will limit ability to communicate with, or understand a practitioner.
- those with coexisting renal diseases , any reported allergy to the given medications.
- legal guardian refusal .
Key Trial Info
Start Date :
September 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06077539
Start Date
September 20 2023
End Date
May 1 2024
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amany Hassan Saleh
Giza, Egypt, 02